Bank Julius Baer & Co’s AtriCure ATRC Stock Holding History

Bank Julius Baer & Co’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-90,444	Closed	-$5.04M	–	819
2020 Q4	$5.04M	Buy	+90,444	New	+$3.91M	0.04%	187

Other funds holding ATRC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank Julius Baer & Co's ATRC Position: Q1 2021 in Review

Bank Julius Baer & Co sold out of AtriCure (ATRC) in Q1 2021, closing a stake of 90,444 shares — an estimated $5.04M sold.

Bank Julius Baer & Co first reported a position in ATRC in Q4 2020 and held it in 1 quarter. The position peaked at $5.04M in Q4 2020. 191 funds tracked by Wall St. Rank hold ATRC as of Q1 2021.

Bank Julius Baer & Co reported no remaining AtriCure position as of Q1 2021 after selling out during the quarter.
Bank Julius Baer & Co sold 90,444 AtriCure shares in Q1 2021, an estimated $5.04M.
Bank Julius Baer & Co first reported a position in AtriCure in Q4 2020 and held it in 1 quarter.
Bank Julius Baer & Co's AtriCure position peaked at $5.04M in Q4 2020.
191 funds tracked by Wall St. Rank held AtriCure as of Q1 2021.

Based on Bank Julius Baer & Co's 13F filing for Q1 2021, filed 10 May 2021.